• Company
• Public opinion grows on if PO kidney tx should be covered
• by Nho, Byung Chul Oct 31, 2023 05:35am

• Company
• Zavicefta nears final negotiations for reimb in KOR
• by Eo, Yun-Ho Oct 31, 2023 05:35am

• Company
• Jyseleca to be launched in earnest next month
• by Eo, Yun-Ho Oct 30, 2023 05:30am

• Company
• Heart failure drug Entresto continues to grow rapidly
• by Kim, Jin-Gu Oct 30, 2023 05:30am

• Policy
• Dupixent receives the green light for reimb extensions
• by Lee, Tak-Sun Oct 30, 2023 05:30am

• Company
• Nic Horridge resigns as CEO of Roche Korea
• by Eo, Yun-Ho Oct 30, 2023 05:29am

• Policy
• NA criticizes HIRA's low prior approval of specific drug
• by Lee, Tak-Sun Oct 30, 2023 05:29am

• Policy
• New dug price reeval standards will be set within the year
• by Lee, Jeong-Hwan Oct 27, 2023 05:33am

• Company
• Nephoxil can be prescribed at general hospitals
• by Eo, Yun-Ho Oct 27, 2023 05:33am

• Policy
• Galvusmet generics released in all dosage forms in KOR
• by Lee, Tak-Sun Oct 27, 2023 05:33am